9-130494867-G-T
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM5PP3PP5_Very_Strong
The NM_054012.4(ASS1):c.971G>T(p.Gly324Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/23 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G324S) has been classified as Pathogenic.
Frequency
Consequence
NM_054012.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASS1 | NM_054012.4 | c.971G>T | p.Gly324Val | missense_variant, splice_region_variant | 13/15 | ENST00000352480.10 | NP_446464.1 | |
ASS1 | NM_000050.4 | c.971G>T | p.Gly324Val | missense_variant, splice_region_variant | 14/16 | NP_000041.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASS1 | ENST00000352480.10 | c.971G>T | p.Gly324Val | missense_variant, splice_region_variant | 13/15 | 1 | NM_054012.4 | ENSP00000253004 | P1 | |
ASS1 | ENST00000372393.7 | c.971G>T | p.Gly324Val | missense_variant, splice_region_variant | 14/16 | 5 | ENSP00000361469 | P1 | ||
ASS1 | ENST00000372394.5 | c.971G>T | p.Gly324Val | missense_variant, splice_region_variant | 14/16 | 2 | ENSP00000361471 | P1 | ||
ASS1 | ENST00000372386.6 | n.242G>T | splice_region_variant, non_coding_transcript_exon_variant | 4/6 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461094Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726866
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Citrullinemia Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 24, 2024 | Variant summary: ASS1 c.971G>T (p.Gly324Val) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Two predict the variant weakens a 3' acceptor site. Two predict the variant strengthens a cryptic 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251114 control chromosomes (gnomAD). c.971G>T has been reported in the literature as a biallelic compound heterozygous genotype in individuals affected with Citrullinemia Type I (example: Martin-Hernandez_2014, Pangalos_2016, Diez-Fernandez_2017, Zielonka_2019). These data indicate that the variant is likely to be associated with disease. To our knowledge, no variant specific experimental evidence demonstrating an impact on protein function has been reported, although compound heterozygous genotypes with decreased ASS1 enzyme activity have been reported (example, Zielonka_2019). The following publications have been ascertained in the context of this evaluation (PMID: 25433810, 28111830, 31469252, 27168972). ClinVar contains an entry for this variant (Variation ID: 458676). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 04, 2023 | This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of citrullinemia (PMID: 25433810, 28111830, 31469252; Invitae). ClinVar contains an entry for this variant (Variation ID: 458676). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 324 of the ASS1 protein (p.Gly324Val). - |
Citrullinemia type I Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 28, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at